Patent · US Expired

Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase

US7297488B2 · kind B2 · utility

13Cited by

32References

12Claims

0Family size

Assignees

Geron Corporation · US
The Regents of the University of Colorado · US

Inventors

Thomas R. Cech · Frederick, US
Joachim Lingner · Épalinges, CH
Toru Nakamura · Boulder, US
Karen B. Chapman · Sausalito, US
Gregg B. Morin · Davis, US
Calvin B. Harley · Palo Alto, US
William H. Andrews · Reno, US

Key dates

Filing date	Aug 8, 2003
Grant date	Nov 20, 2007
Priority date	—
Expiry date	Aug 8, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/315
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides TRT antisense oligonucleotides, methods of detecting TRT, methods of diagnosing telomerase-related conditions, methods of diagnosing and providing a prognosis for cancer, and methods of treating telomerase-related conditions, including cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.